We have observed
13 EP applications
Hilary Mary van der Hoff
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 02, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PEG-INTERFERON LAMBDA 1 CONJUGATES
VEGF/DLL4 BINDING AGENTS AND USES THEREOF
IMMUNOCYTOKINE COMBINATION THERAPY
METHODS FOR TREATING HYPERURICEMIA IN PATIENTS WITH GOUT USING HALOFENATE OR HALOFENIC ACID AND A SECOND URATE-LOWERING AGENT
TAXANE AND ABEO-TAXANE ANALOGS
METHODS FOR TREATING GOUT FLARES
METHODS FOR TREATING GOUT IN PATIENT SUBPOPULATIONS
HUMAN NOTCH RECEPTOR MUTATIONS AND THEIR USE
ACID-LABILE LIPOPHILIC PRODRUGS OF CANCER CHEMOTHERAPEUTIC AGENTS
Metal delivery agents and terapeutic uses of the same
CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS
RSPO BINDING AGENTS AND USES THEREOF
BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION (AMD)